(Unaudited data)

  • Cumulative activity as of the end of december 2014













thousands of euros20132014Variation at current exchange ratesVariation at constant exchange rates
France346,965343,891- 0.9%- 0.9%
         
International :270,766265,857- 1.8%+ 2.7%
Incl. Europe excluding France204,283198,918- 2.6%+ 2.8%
Incl. North America53,36452,813- 1.0%+ 0.3%
Incl. Other countries13,11914,126+ 7.7%+ 9.6%
Group Total617,731609,748- 1.3%+ 0.7%

 

thousands of euros20132014Variation at current exchange ratesVariation at constant exchange rates
Non-proprietary Homeopathic Medicines305,739305,501- 0.1%+ 0.0%
OTC Specialties311,581303,549- 2.6%+ 1.2%
Other411698+ 69.8%+ 67.6%
Group Total617,731609,748- 1.3%+ 0.7%


  • Quarterly activity in 2014 ( variation at current rate)
 1st Quarter2nd Quarter3rd Quarter4th Quarter
thousands of euros20132014Var. 14/1320132014Var. 14/1320132014Var. 14/1320132014Var. 14/13
France84,27082,749- 1.8%75,32774,269- 1.4%92,59692,466- 0.1%94,77294,407- 0.4%
                         
International :73,75157,460-22.1%42,43647,138+11.1%76,89079,646+3.6%77,68981,613+5.1%
Incl.Europe excluding France54,33439,967- 26.4%29,04733,570+ 15.6%61,25662,758+ 2.5%59,64662,623+5.0%
Incl. North America15,56212,662- 18.6%10,01710,625+ 6.1%12,15313,109+ 7.9%15,63216,417+5.0%
Incl. Other countries3,8554,831+25.3%3,3722,943- 12.7%3,4813,779+ 8.6%2,4112,573+6.7%
Group Total158,021140,209-11.3%117,763121,407+ 3.1%169,486172,112+1.5%172,461176,020+2.1%

 

 1st Quarter2nd Quarter3rd Quarter4th Quarter
thousands of euros20132014Var. 14/1320132014Var. 14/1320132014Var. 14/1320132014Var. 14/13
Non-proprietary Homeopathic Medicines79,06277,919- 1.4%73,03573,072+ 0.1%73,59772,957- 0.9%80,04581,553+ 1.9%
OTC Specialties78,86662,196-21.1%44,60048,058+ 7.8%95,81399,025+ 3.4%92,30294,270+ 2.1%
Other9394+1.1%128277+116.4%76130+71.1%114197+72.8%
Group Total158,021140,209-11.3%117,763121,407+ 3.1%169,486172,112+ 1.5%172,461176,020+ 2.1%


Highlights of the fourth quarter

  • Sales revenue in the fourth quarter of 2014 grew by 2.1% (5.1% at constant rate).
  • Given the evolution of business and the control of costs, the 2014 operating income should grow in comparison to 2013.
  • On December 31, 2013, the group's net cash position is close to 156 million euros.


On January 19, 2015, the Superior Court of Montreal rejected the complaint aiming at launching a class action proceeding filed on April 13, 2012.



Our next update: March 18, 2015, after the close of the stock market, publication of 2014 results.
Financial information manager: Christian Boiron
Contact for financial information: Véronique Bouscayrol
Investor relations: +33 (0) 4.78.45.63.43 - e-mail: finances@boiron.fr
ISIN Code: FR0000061129 (BOI) - Bloomberg: BOI FP - Reuters: BOIR.PA
The group's financial information is online at : www.boironfinance.com

Information réglementée
Communiqués au titre de l′obligation d′information permanente :
- Communiqué sur comptes, résultats, chiffres d′affaires
Communiqué intégral et original au format PDF :
http://www.actusnews.com/documents_communiques/ACTUS-0-38559-BOI-220115-CA-14-GB.pdf
© Copyright Actusnews Wire
Recevez gratuitement par email les prochains communiqués de la société en vous inscrivant sur www.actusnews.com
Receive by email the next press releases of the company by registering on www.actusnews.com, it′s free


© 2015 ActusNews